Author: healthylife7

SINGAPORE, July 8, 2026 /PRNewswire/ — Novo Nordisk announced an update to the Singapore label for semaglutide, approved in Singapore as Wegovy® (semaglutide) injection, incorporating clinical evidence from the STEP UP trial in adults living with obesity without diabetes. In the trial, which evaluated a higher dose of semaglutide (7.2 mg), up to one in three…

Read More

July 8, 2026 /PRNewswire/ — Blue Owl Capital Inc. (“Blue Owl”) (NYSE: OWL), a leading alternative asset manager, today announced that funds managed by Blue Owl, together with Moor Park Capital Partners (“Moor Park”), have successfully completed the acquisition of a portfolio of 12 acute-care hospitals operated by Spire Healthcare Group plc, the UK’s leading…

Read More